Patent ID: 9132131
Filing Date: 2015-09-15
Classification: A61K,A61P

Abstract:
1. A method of treating a mammalian subject experiencing neuropathic pain, comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of an A 3 AR agonist selected from the group consisting of: N 6 -(3-iodobenzyl)-adenosine-5′-N-methyluronamide; 2-chloro-N 6 -(3-iodobenzyl)-adenosine-5′-N-methyluronamide; (1R,2R,3S,4R)-4-(2-chloro-6-((3-chlorobenzyl)amino)-9H-purin-9-yl)-2,3-di-hydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide; (2S,3S,4R,5R)-3-amino-5-[6-(2,5-dichlorobenzylamino)purin-9-yl]-4-hydroxytetrahydrofuran-2-carboxylic acid methylamide; (1′S,2′R,3′S,4′R,5′S)-4-(2-chloro-6-(3-chlorobenzylamino)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide; 2-(1-hexynyl)-N 6 -methyladenosine); (1S,2R,3S,4R)-2,3-dihydroxy-4-(6-((3-iodobenzyl)amino)-4H-purin-9 (5H)-yl)-N-methylcyclopentanecarboxamide); (1S,2R,3S,4R)-4-(2-chloro-6-((3-iodobenzyl)amino)-4H-purin-9 (5H)-yl)-2,3-dihydroxy-N-)methylcyclopentanecarboxamide; 2-cyclohexyl-N-(3,4-dichlorophenyl)-1H-imidazo[4,5-c]quinolin-4-amine; (1′R,2′R,3′S,4′R,5′S)-4-{2-chloro-6-[(3-iodophenylmethyl)amino]purin-9-yl-}-1-(methylaminocarbonyl)-bicyclo[3.1.0]hexane-2,3-diol, and combinations thereof.